Phase II trial of fludarabine alternating with interferon (IFN)alpha 2B in low grade non-Hodgkin's lymphoma (NHL)

被引：0
|
作者：
Smith, MR
Boyd, RL
Minnitti, C
Clyde, J
Hoessly, MC
Cornfeld, M
Yeslow, G
Halbherr, T
Rogatko, A
Schilder, RJ
Young, RC
Millenson, MM
机构：
[1] FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
[2] FOX CHASE NETWORK,PHILADELPHIA,PA 19111
来源：
BLOOD | 1997年 / 90卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：861 / 861
页数：1
相关论文
共 50 条
  • [31] Results of a phase I/II trial of pixantrone in combination with fludarabine, dexamethasone, and rituximab in the treatment of patients with relapsed/refractory indolent non-Hodgkin's lymphoma (NHL).
    Fayad, Luis
    Liebmann, James
    Modiano, Manuel
    Cohen, Gary
    Pro, Barbara
    Romaguera, Jorge
    Stromatt, Scott
    BLOOD, 2006, 108 (11) : 781A - 781A
  • [32] Effectiveness of interferon-alfa (IFN-α) added to an anthracycline-based regimen in treating low grade (LG) and intermediate grade (IG) non-Hodgkin's lymphoma (NHL).
    Enschede, SH
    Shahidi, H
    Venugopal, P
    Riley, MB
    Huang, R
    Jajeh, A
    Preisler, HD
    Gregory, SA
    BLOOD, 1998, 92 (10) : 412A - 412A
  • [33] De Quervain's thyroiditis associated with interferon-α-2b therapy for non-Hodgkin's lymphoma
    Fortis, A
    Christopoulos, C
    Chrysadakou, E
    Anevlavis, E
    CLINICAL DRUG INVESTIGATION, 1998, 16 (06) : 473 - 475
  • [34] De Quervain’s Thyroiditis Associated with Interferon-α-2b Therapy for Non-Hodgkin’s Lymphoma
    A. Fortis
    C. Christopoulos
    E. Chrysadakou
    E. Anevlavis
    Clinical Drug Investigation, 1998, 16 : 473 - 475
  • [35] Phase I/II trial of pamidronate and interleukin-2 (IL-2) for relapsed/refractory multiple myeloma (MM) and low-grade non-Hodgkin's lymphoma (NHL).
    Kunzmann, V
    Kelm, K
    Eckstein, S
    Wilhelm, M
    BLOOD, 2000, 96 (11) : 733A - 733A
  • [36] Multicenter phase II study of oral fludarabine phosphate (FAMP) in relapsed indolent B-cell non-Hodgkin lymphoma (B-NHL)
    Morishima, Y
    Ogura, M
    Tobinai, K
    Minami, H
    Hayashi, M
    Hotta, T
    ANNALS OF ONCOLOGY, 2005, 16 : 155 - 155
  • [37] Alpha-interferon for relapsed non-Hodgkin's lymphoma
    A E Armitage
    J D Armitage
    J O Armitage
    Bone Marrow Transplantation, 2006, 38 : 701 - 702
  • [38] Alpha-interferon for relapsed non-Hodgkin's lymphoma
    Armitage, A. E.
    Armitage, J. D.
    O Armitage, J.
    BONE MARROW TRANSPLANTATION, 2006, 38 (10) : 701 - 702
  • [39] Results of a fludarabine induction and alpha-interferon maintenance protocol in pretreated patients with chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma
    Zinzani, PL
    Bendandi, M
    Magagnoli, M
    Rondelli, D
    deVivo, A
    Benni, M
    Zamagni, E
    Cavo, M
    Tura, S
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1997, 59 (02) : 82 - 88
  • [40] Phase I/II Study of Dasatinib In Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
    William, Basem M.
    Hohenstein, Maribeth
    Loberiza, Fausto R., Jr.
    Caponetti, Gabriel C.
    Bociek, R. Gregory
    Bierman, Philip
    Armitage, James O.
    Chan, Wing-Chung
    Vose, Julie M.
    BLOOD, 2010, 116 (21) : 131 - 131
12345